139 related articles for article (PubMed ID: 15980952)
1. High iron storage levels are associated with increased DNA oxidative injury in patients on regular hemodialysis.
Yoshimura K; Nakano H; Yokoyama K; Nakayama M
Clin Exp Nephrol; 2005 Jun; 9(2):158-63. PubMed ID: 15980952
[TBL] [Abstract][Full Text] [Related]
2. Effect of repeated intravenous iron administration in haemodialysis patients on serum 8-hydroxy-2'-deoxyguanosine levels.
Maruyama Y; Nakayama M; Yoshimura K; Nakano H; Yamamoto H; Yokoyama K; Lindholm B
Nephrol Dial Transplant; 2007 May; 22(5):1407-12. PubMed ID: 17264097
[TBL] [Abstract][Full Text] [Related]
3. Protective effect of vitamin C on 8-hydroxy-2'-deoxyguanosine level in peripheral blood lymphocytes of chronic hemodialysis patients.
Tarng DC; Liu TY; Huang TP
Kidney Int; 2004 Aug; 66(2):820-31. PubMed ID: 15253739
[TBL] [Abstract][Full Text] [Related]
4. 8-hydroxy-2'-deoxyguanosine of leukocyte DNA as a marker of oxidative stress in chronic hemodialysis patients.
Tarng DC; Huang TP; Wei YH; Liu TY; Chen HW; Wen Chen T; Yang WC
Am J Kidney Dis; 2000 Nov; 36(5):934-44. PubMed ID: 11054349
[TBL] [Abstract][Full Text] [Related]
5. Effect of vitamin E-bonded membrane on the 8-hydroxy 2'-deoxyguanosine level in leukocyte DNA of hemodialysis patients.
Tarng DC; Huang TP; Liu TY; Chen HW; Sung YJ; Wei YH
Kidney Int; 2000 Aug; 58(2):790-9. PubMed ID: 10916104
[TBL] [Abstract][Full Text] [Related]
6. Anemia management of adult hemodialysis patients in the US results: from the 1997 ESRD Core Indicators Project.
Frankenfield D; Johnson CA; Wish JB; Rocco MV; Madore F; Owen WF
Kidney Int; 2000 Feb; 57(2):578-89. PubMed ID: 10652035
[TBL] [Abstract][Full Text] [Related]
7. Blood 8-hydroxy-2'-deoxyguanosine is associated with erythropoietin resistance in haemodialysis patients.
Kato A; Odamaki M; Hishida A
Nephrol Dial Transplant; 2003 May; 18(5):931-6. PubMed ID: 12686667
[TBL] [Abstract][Full Text] [Related]
8. Effect of intravenous ascorbic acid in hemodialysis patients with EPO-hyporesponsive anemia and hyperferritinemia.
Attallah N; Osman-Malik Y; Frinak S; Besarab A
Am J Kidney Dis; 2006 Apr; 47(4):644-54. PubMed ID: 16564942
[TBL] [Abstract][Full Text] [Related]
9. Low levels of serum ferritin and moderate transferrin saturation lead to adequate hemoglobin levels in hemodialysis patients, retrospective observational study.
Ogawa C; Tsuchiya K; Tomosugi N; Kanda F; Maeda K; Maeda T
PLoS One; 2017; 12(6):e0179608. PubMed ID: 28662118
[TBL] [Abstract][Full Text] [Related]
10. Elevation of blood thioredoxin in hemodialysis patients with hepatitis C virus infection.
Kato A; Odamaki M; Nakamura H; Yodoi J; Hishida A
Kidney Int; 2003 Jun; 63(6):2262-8. PubMed ID: 12753316
[TBL] [Abstract][Full Text] [Related]
11. The influence of hepatitis C and iron replacement therapy on plasma pentosidine levels in haemodialysis patients.
Nascimento MM; Suliman ME; Bruchfeld A; Hayashi SY; Manfro RC; Qureshi AR; Pecoits-Filho R; Pachaly MA; Renner L; Stenvinkel P; Riella MC; Lindholm B
Nephrol Dial Transplant; 2004 Dec; 19(12):3112-6. PubMed ID: 15466879
[TBL] [Abstract][Full Text] [Related]
12. Association between transferrin receptor-ferritin index and conventional measures of iron responsiveness in hemodialysis patients.
Chen YC; Hung SC; Tarng DC
Am J Kidney Dis; 2006 Jun; 47(6):1036-44. PubMed ID: 16731299
[TBL] [Abstract][Full Text] [Related]
13. Intravenous iron administration induces oxidation of serum albumin in hemodialysis patients.
Anraku M; Kitamura K; Shinohara A; Adachi M; Suenga A; Maruyama T; Miyanaka K; Miyoshi T; Shiraishi N; Nonoguchi H; Otagiri M; Tomita K
Kidney Int; 2004 Aug; 66(2):841-8. PubMed ID: 15253741
[TBL] [Abstract][Full Text] [Related]
14. 2008 Japanese Society for Dialysis Therapy: guidelines for renal anemia in chronic kidney disease.
Tsubakihara Y; Nishi S; Akiba T; Hirakata H; Iseki K; Kubota M; Kuriyama S; Komatsu Y; Suzuki M; Nakai S; Hattori M; Babazono T; Hiramatsu M; Yamamoto H; Bessho M; Akizawa T
Ther Apher Dial; 2010 Jun; 14(3):240-75. PubMed ID: 20609178
[TBL] [Abstract][Full Text] [Related]
15. [Iron replacement in hemodialysis patients with a normal serum ferritin level].
Riedel MK; Morgenstern T
Dtsch Med Wochenschr; 2004 Sep; 129(36):1849-53. PubMed ID: 15368155
[TBL] [Abstract][Full Text] [Related]
16. [Multi-frequency low-dose intravenous iron on oxidative stress in maintenance hemodialysis patients].
Yin L; Chen X; Chen J; Cheng M; Peng Y; Yang L
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2012 Aug; 37(8):844-8. PubMed ID: 22954919
[TBL] [Abstract][Full Text] [Related]
17. [Assessment of iron requirements during treatment of anemia with recombinant human erythropoietin in patients with chronic renal insufficiency under hemodialysis].
Oliveira C; Boquinhas H; Gaspar A; Adragão T; Boquinhas JM; Júnior EC; Simões J
Acta Med Port; 1992 Jul; 5(7):351-7. PubMed ID: 1442178
[TBL] [Abstract][Full Text] [Related]
18. Oxidative DNA damage and mortality in hemodialysis and peritoneal dialysis patients.
Xu H; Watanabe M; Qureshi AR; Heimbürger O; Bárány P; Anderstam B; Eriksson M; Stenvinkel P; Lindholm B
Perit Dial Int; 2015; 35(2):206-15. PubMed ID: 24584621
[TBL] [Abstract][Full Text] [Related]
19. Association between serum ferritin and lipid peroxidation in hemodialysis patients.
Pedruzzi LM; Cardozo LF; Medeiros RF; Stockler-Pinto MB; Mafra D
J Bras Nefrol; 2015; 37(2):171-6. PubMed ID: 26154636
[TBL] [Abstract][Full Text] [Related]
20. Greater potency of darbepoetin-α than erythropoietin in suppression of serum hepcidin-25 and utilization of iron for erythropoiesis in hemodialysis patients.
Shoji S; Inaba M; Tomosugi N; Okuno S; Ichii M; Yamakawa T; Kurihara S
Eur J Haematol; 2013 Mar; 90(3):237-44. PubMed ID: 23281632
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]